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บทคดัยอ่ 
วตัถปุระสงค์: เพื่อประเมินผลการใช้กระบวนการเยี่ยมบ้านตามคู่มือและ
หลกัเกณฑก์ารปฏบิตังิานเยีย่มบ้านผูป่้วยโดยเภสชักรครอบครวัของโรงพยาบาล
สมุทรสาครสามารถตอ่จ านวนคนไขท้ีแ่บ่งตามระดบัความจ าเป็นในการออกเยีย่ม 
วิธีการศึกษา: การศึกษาแบบกึ่งทดลองนี้ เป็นส่วนหนึ่งของการพัฒนาแนว
ทางการเยี่ยมบ้านส าหรบัเภสชักรครอบครวั โรงพยาบาลสมุทรสาคร ตัง้แต่
มิถุนายนถึงธนัวาคม 2558 โดยเน้นที่การปฏิบัติงานเยี่ยมบ้านตามคู่มือและ
หลกัเกณฑ์การปฏบิตังิานฯ คดัเลอืกคนไขท้ีม่คีวามจ าเป็นในการเยีย่มบา้นระดบั 
A (จ าเป็นทีสุ่ด) และ B จ านวน 15 ราย โดยแบ่งตามระดบัปัญหาเกีย่วกบัการใช้
ยาและความทุกขจ์าการใชย้า แลว้ตดิตามเยีย่มและประเมนิระดบัความจ าเป็นอกี
ครัง้ แสดงผลคนไขเ้ฉพาะราย และแสดงความถีแ่ละรอ้ยละ ผลการศึกษา: คนไข้
ทัง้หมด 15 รายทีผ่่านการคดัเลอืกเป็นระดบั A สว่นมากถูกส่งมาโดยเภสชักรงาน
บริบาลทางเภสชักรรมในผู้ป่วยใน (11 ราย) ส่วนใหญ่เป็นเพศหญิง (ร้อยละ 
60.00) อายุเฉลีย่ 61 ปี สถานภาพคู ่(รอ้ยละ 46.67) ไมไ่ดป้ระกอบอาชพี (รอ้ยละ 
80) ใช้สทิธหิลกัประกนัสุขภาพถ้วนหน้า (UC) (รอ้ยละ 93.33) มผีูดู้แลการใช้ยา 
(รอ้ยละ 60.00) โดยผูป่้วย 15 รายนี้ ไดร้บัการเยีย่มบา้นรวม 47 ครัง้ เฉลีย่ 3 ครัง้
ตอ่ราย (ช่วง 1 – 7 ครัง้) เมือ่สิน้สุดการเกบ็ขอ้มลู ผูป่้วยสว่นมากยงัอยูใ่นระดบั A 
(รอ้ยละ 60) และที่เหลอืทัง้หมด (ร้อยละ 40) เปลีย่นจากระดบั A เป็น B สรปุ: 
การเยีย่มบา้นโดยเภสชักรครอบครวัตามคูม่อืและหลกัเกณฑ์การปฏบิตังิานเยีย่ม
บา้นโดยเภสชักรครอบครวัของโรงพยาบาลสมุทรสาครสามารถด าเนินการไดจ้รงิ 
และท าใหค้วามจ าเป็นในการเยีย่มบา้นลดจากระดบั A เป็นระดบั B ไดร้อ้ยละ 40 
ของคนไข ้การศกึษาในอนาคตควรเพิม่จ านวนคนไขแ้ละระยะเวลาในการเยีย่ม
บา้นเพือ่ใหส้ามารถเยีย่มไดห้ลายครัง้ขึน้     
ค าส าคญั: เภสชักรครอบครวั, หลกัเกณฑก์ารเยีย่มบา้น, ปัญหาทีเ่กีย่วกบัการใช้
ยา, ความทุกขท์ีเ่กีย่วกบัการใชย้า  
 
Abstract 
Objectives: To determine the effect of home visit using guideline for 
pharmacists at Samutsakhon Hospital on the patient’s need for home visit. 
Methods: This quasi-experiment study was the second part of the research 
and development study to develop the guideline for home visits for family 
pharmacists conducted from June to December 2015. Fifteen patients with 
level A of need for home visit (i.e., the highest need) and level B were subject 
to recruitment. Drug related problems and sufferings were considered in 
grading these need levels. After home visits, level of home visit need was 
re-evaluated. Findings on individual patients, as well as, frequency with 
percentage were presented. Results: All 15 patients were in level A of home 
visit need. Most were transferred for home visit by pharmacists in in-patient 
pharmaceutical care service (11 patients). The majority were female 
(60.00%), married (46.67%), having no job (80.00%), using universal care 
scheme (93.33%), having caregiver (60.00%), with a mean age of 61 years. 
Of a total of 47 home visits, 3 home visits were made per patient with a 
range of 1 to 7 visits. At the end of the study, the majority of the patients 
stayed at level A (60.00%), while the rest 40.00% were alleviated to level B. 
Conclusion: Home visits by family pharmacists using the guideline 
established for Samutsakhon Hospital were executable and could alleviate 
the need level from A to B in 40% of patients. Future research with a larger 
sample size and a longer follow-up period should be conducted.  
Keywords: family pharmacist, guideline for home visit, drug related 
problems, drug related sufferings  
 
Introduction 
In Thailand, home healthcare has been mostly provided 
by the official community health volunteers, healthcare 
providers of the sub-district health service office, or nurses 
from community hospitals. It was documented that home 
healthcare service in the remote area by physicians was 
provided in 1978.1 Recently, more physicians, especially those 
specialized in family medicine have increasingly taken more 
role in home healthcare service. In the National Health 
Security Act B.E. 2545 (A.D. 2002), home healthcare is 
included in the benefit package for the national universal 
coverage. This Act mandates that family medicine or family 
practice be provided at the primary care unit to satisfy the 
clients than does the conventional care.2  Meanwhile, nurses 
have been developing their primary nursing care as mandated 
by the Professional Nursing and Midwifery Act B.E. 2528 (A.D. 
1985). As a result, their patient care has been extended from 
hospital nursing care to home and community healthcare 
service.3  
Home healthcare by family pharmacists is one of the five 
primary pharmacy services stated in the National Health 
Security Act B.E. 2545 (A.D. 2002). In the Act, pharmacy 
home healthcare service is under the section of the continuous 
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medication management system in the community. Home 
healthcare by family pharmacists in various hospitals has been 
conceived with different concepts and processes as a result 
of diverse problems, resources, populations, and levels of 
healthcare settings. Consequently, standard home healthcare 
practice has not been established for the nation-wide as a 
benchmark for regular practice as well as assessment for 
family pharmacists.  
In 2009, the Office of Service Quality Development, 
Ministry of Public Health, in association with Drugs, Medical 
Supplies and Vaccines Fund of the National Health Security 
Office, and the Consumer Health Protection project under the 
Thai Health Promotion Foundation initiated the project entitled 
“the Development of the Community Pharmacy Service” to 
improve the performance of family pharmacists in primary care 
unit, to develop the protocol for pharmacy primary care 
service, and to strategically plan for human resource 
development. One of the family pharmacy practice 
components is the community–based pharmaceutical care 
with clinical guidelines for select illnesses. This practice aims, 
among patients and their families, to improve medication 
adherence, to self-manage medication use, and to achieve a 
safe and effective use of medications and health products. In 
addition, the practice also aims to effectively allocate budget 
to the development of the primary care unit.4,5  
In 2014, the Hospital Pharmacy Association of Thailand 
initiated the support for the community of pharmacy practice 
(COP). Such campaign has encouraged the collaboration of 
hospital pharmacists and faculty members in various fields of 
pharmacy practice. To thrive for excellence in pharmacy 
practice, these parties shared their experiences and obstacles 
in their works. In 2012, pharmacists who had been working in 
primary pharmaceutical care formed the group called the 
Society of Family Pharmacist-Thailand (SOFT). The SOFT 
group aimed to identify and solve drug-related problems in the 
patients from the hospital to their residence. The vision of 
SOFT facilitated pharmacists to engage more in home 
healthcare.6  
In a continuum of seamless and continuous care, 
processes of care from institutional to residential need to be 
identified. Specific services provided by pharmacists to 
identify, solve and prevent drug-related problems, at each 
point of care must be strictly followed. This is because, like 
services provided by other healthcare professionals, drug-
related problems have been found considerably prevalent at 
the seam of the care. For example, an incomplete history of 
medication use from the previous hospital could lead to 
missing certain medications at the present hospital admission 
if medication reconciliation is not performed. In addition, 
medication regimen could be changed for hospitalized 
patients. Without discharge counseling, any misunderstanding 
on the medication regimen after leaving the hospital could lead 
the patients to an unintended medication use.7-9  
In Samutsakorn Hospital, the family pharmacy healthcare 
service was initiated in 2011 to verify the actual cause of the 
patient’s drug-related problems at their residence. At the early 
phase, only one pharmacist provided the service by joining 
the hospital’s nursing home healthcare team. This pharmacist 
also cooperated with sub-district health promoting hospitals 
under the provision Samutsakorn Hospital. In 2013, a total of 
four pharmacists were responsible for the home healthcare in 
addition to their other routine services in the hospital. In each 
of their weekly home healthcare visit, two pharmacists made 
a trip to the patient’s house. Since 2012 to November 2014, 
224 home visits for 122 patients had been done. These were 
patients with chronic diseases including hypertension and 
diabetes (48.36%), kidney diseases (20.49%), heart diseases 
(9.01%), cerebrovascular diseases (6.56%), psychiatric 
disorders (5.73%), asthma and chronic obstructive pulmonary 
disease (5.73%), and HIV and pulmonary tuberculosis 
(4.09%).  
A number of patients larger than 122 were with the need 
for home visit. However, with verbal not documented referrals 
from other departments in the hospital to the pharmacy 
department, only 122 patients were visited. In selecting 
patients for home visit, family pharmacists categorized these 
patients into different levels of need specifically A, B, C and 
D. Being mutually agreed among family pharmacists, these 
need levels helped  facilitate the management of home visit. 
In our initial phase, the family pharmacist team could partially 
provide the seamless care. This was in part due to a lack of 
well-established protocol. Some steps were missing from the 
existing initial protocol. For example, criteria for selecting and 
referring cases to the pharmacy home healthcare team, 
appropriate criteria for categorizing the patient’s problem 
severity, specific guideline for planning scheduled visits for 
given patients, guideline for cooperation among involving 
parties, and appropriate outcome measures. With the need to 
improve the quality of pharmaceutical home healthcare 
service of Samutsakorn Hospital, we conducted a research 
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and development project entitled the development of the 
Guideline for Home Visits for Family Pharmacists, and this 
research article is a part of the project report.  
In this study, drug related problems (DRPs) were defined 
based on the work of Cipolle and colleagues10 including 
unnecessary drug therapy, wrong drug, dosage too low, 
dosage too high, need for additional drug therapy, adverse 
drug reactions, and inappropriate compliance. Regarding 
inappropriate compliance, we used the term “non-adherence” 
which could be further categorized into nine groups including 
self-dose decrease, self-dose increase, self-discontinuation, 
irregular use, discontinuation of drugs, redundant drugs with 
similar pharmacological action, wrong administration of drugs, 
wrong drugs, and drugs affecting the desired outcomes of the 
given drugs. In addition to DRPs, we employed the concept of 
drug-related sufferings (DRSs) based on the work of 
Wisetsorn1 1 ,12 to reflect a holistic impact of drug use on the 
patient’s life. Based on this concept, six sufferings were 
identified. First, the patient could lose certain functions in their 
daily living because of drug use such as the drugs’ adverse 
drug reactions (ADRs). Second, the patient could experience 
stress and anxiety associated with drug use and related side 
effects. Such psychological distress could lead certain patients 
to a reluctance or fear to use the drug. Third, confidence in 
drug use could be lost in some patients. Fourth, caregivers 
could also face stress in taking care of drug use for the patient. 
Fifth, some patients perceived that their drug use is a burden 
to the others. Sixth, relationship among family members could 
be negatively affected by various conflicts, for example, the 
patient’s annoyance once reminded by family members to take 
drugs.  
In categorizing the patient’s need for home visit, we 
considered two aspects of their drug related problems, namely 
the severity and urgency of the problem. Severity of the 
problem was defined as how severe the undesirable outcomes 
could be if not corrected or controlled. Urgency was defined 
as how fast the problem needed correction or control before 
the undesirable outcomes occurred or worsened. To reach a 
set of comprehensive criteria, four levels of need, specifically 
A, B, C and D were created. The level A of need was defined 
as patients with the highest need for home visit. They could 
be those new cases referred from family pharmacists at any 
settings in the hospital. They had DRPs and/or DRSs, or their 
diseases uncontrolled. Those with level B need referred to 
patients whose DRPs and DRSs had been corrected but their 
diseases had not been well controlled and other health-related 
problems, such as inappropriate behaviors affecting 
adherence, had been found. For C-level need, neither DRPs 
nor DRSs had been found. Other health-related problems had 
also been resolved. Finally, D-level need was defined as those 
with all problems resolved and follow-up was no longer 
needed and hence terminated. The use of need-based criteria 
incorporating severity and urgency of the problems was 
considered comprehensive. In this present research report, 
the specific objective was to preliminarily determine how the 
levels of need for home visit, i.e., A, B, C and D, changed 
after the use of the Guideline for Home Visits for Family 
Pharmacists of Samusakorn Hospital.  
   
Methods 
 
This quasi-experiment study was the second phase of the 
research and development project entitled the development of 
the Guideline for Home Visits for Family Pharmacists of 
Samusakorn Hospital from June to December 2015. In phase 
1, situational analysis was conducted and guideline including 
the protocol for home visits provided by family pharmacists 
was developed. In the second phase, family pharmacists 
including the researcher (Salisa Saploy) made home visits to 
selected patients using the developed guideline.  
In this second phase, the outcome was the proportion of 
patients in each level of need for home visit before and after 
the home visit using the guideline. Need levels, i.e., A, B, C 
and D, were the results of DRPs, DRSs, disease control status 
and other health-related problems as previously described. 
This consideration was based on the concept that all relevant 
aspects of problems and factors should be taken into account 
in classifying the need for home visit. To be able to see clear 
changes in level of need, only patients with moderate to high 
levels of need, i.e., levels A and B, were selected.  
Based on the developed guideline and protocol, not only 
family pharmacists but also other professionals were involved 
in the home healthcare service. These 16 professionals 
including physicians, nurses, nutritionists, and social workers 
were selected by a purposive sampling method. These 
professionals were involved in home healthcare visit of 
Samutsakorn Hospital and had worked at the hospital for at 
least two years. In the actual practice, these professionals 
took part in choosing the patients for home visit, and providing 
opinion, advice and information relevant to their expertise. For 
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physicians, they helped select the patients with the need for 
home visit and provided consultation when asked by the home 
visiting team. These physician specialists included one with 
social medicine and the other with internal medicine. Six 
nurses with various responsibilities were included. 
Samutsakorn Hospital was responsible for home healthcare of 
the patients living in Muang district area. We selected a home 
healthcare nurse who was taking care of patients residing in 
the municipal area of Muangdistrict. The other nurse from the 
social medicine department of the hospital was selected as 
she took care of patients living in sub-districts out of the 
municipal area of Muang district. In visiting those patients out 
of the municipal area, the coordination between the team of 
Samutsakorn Hospital and those of sub-district health 
promoting hospitals was needed. Therefore we selected a 
nurse from a sub-district health promoting hospital to facilitate 
home visit in this study. Another nurse selected was the one 
responsible for psychiatric home healthcare visit of 
Samutsakorn Hospital. The fifth selected nurse was 
responsible for continuous ambulatory peritoneal dialysis 
(CAPD) who also made home visits for CAPD patients. Finally, 
a nurse in internal medicine department was selected. This 
nurse was responsible for home visit for chronic illness 
patients with any health-related problems. In this study, six 
family pharmacists participated in the thorough process of 
home healthcare. They were involved in identifying the 
patients’ DRPs, DRSs, other health-related problems, and 
disease control status which were necessary for classifying 
the patient into each of the four levels of need, i.e., A, B, C 
and D, for home visit. In addition to their routine 
pharmaceutical care service both in the in-patient and out-
patient departments of the hospital, these six family 
pharmacists also provided the home healthcare service. We 
selected one social worker responsible for home visit to take 
care of patients with social problems including family problem, 
abandoned elderly and children, and family financial problem. 
Finally, a nutritionist responsible for home visit for patients with 
nutrition problems.    
For patient sample, we also selected them by the 
purposive sampling method. The patients had DRPs and were 
screened and referred from various points of care in the 
hospital. They were referred by pharmacists, physicians, 
nurses in Samutsakorn and sub-district health promoting 
hospitals, social worker, and nutritionist, from out-patient and 
in-patient departments and home visit. In this preliminary 
study, we selected only 15 patients for as many visits as 
possible within the limited period of time. In general, we 
intended to make at least three visits to obtain adequate 
information for future study. However, if any patients were 
found to have less severe and urgent problems, they could be 
re-assessed for outcomes (need level) at the second visit. For 
those whose severe and urgent problems persisted, the third 
visit was needed. The selected patients were in accordance 
with the criteria stated in the developed guideline. There were 
considered based on the severity and urgency of their 
problems as follows. The patients with redundant medications 
or medications with a high potential for drug interactions. They 
were patients with chronic illnesses who had a risk of wrong 
drug administration, who were frequently hospitalized with 
DRPs, whose health problems were not corrected or 
alleviated, and who used a large number of drugs, for 
example, those with chronic kidney disease. At the start of the 
study, if any of these problems led to a severe and urgent 
outcome, the patient was classified as a level A of need for 
home visit regardless of their experience with home visit. In 
addition, those with a recurrence of the previously solved 
problem were also classified as level A. Patients with level A 
of need were subject to a re-visit within three months and 
follow-up phone calls. Three visits and re-assessments were 
planned for these A-level patients. For patients with less 
severe and urgent problems, re-assessment of the need at 
visit two could be made. However, if the severity and urgency 
remained high, the re-assessment at the third visit was 
needed. The re-assessment at the second or third visit could 
result in B, C, or D level (Figure 1). Patients with level B of 
need at the start of the study were those whose problems 
were resolved but their diseases were not well controlled and 
with other health-related problems such as inappropriate 
behaviors that could lead medication non-adherence. This 
group of patients was subject to a re-visit within six months 
and re-assessments similar to those in level A. Even though 
not included in our study, patients with C-level of need were 
those subject to regular scheduled visit mainly by the hospital. 
Once three visits were completed, re-assessment was made. 
In addition, patients with B- or C-level of need could be re-
classified as level A.    
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Figure 1 Level of need for home visit.   
   
Research tools  
This study employed three sets of tools including 1) 
Guideline for Home Visits for Family Pharmacists of 
Samutsakhon Hospital, 2) data collection forms consisting of 
home pharmaceutical care record form, DRP and DRS record 
form, and problem summary and management form, and 3) 
HOSxP electronic database program and conventional 
medical records of Samutsakorn Hospital.  
 
Home visit procedure  
Home visits had been made from June 1st to December 
30th, 2015. Based on the developed guideline, only patients 
with level A and B of need were selected and scheduled for 
home visit. In each home visit, the researcher (Salisa Saploy), 
and two family pharmacists joined the team. Among these 
family pharmacists, one was acting as the case manager. In 
addition to family pharmacists, other professionals, if 
available, also joined the team. Home visit was scheduled 
once a week with three patients to visit. Information of the 
patients’ medical records were communicated among all 
professionals through the TurboHOSxP program. The team 
telephoned the patient or their relatives for home visit consent. 
If agreed, the team asked the patient for traveling information 
and searched for maps and remarks from the internet. 
Additional phone numbers of the patient were also requested. 
In each trip, visits for three patients living close to each other 
were scheduled for time-saving purpose. Failed visit, if any, 
was rescheduled for the following week.  
In addition to TurboHOSxP program, information of the 
patient before and after home visit was also conveniently 
shared amongall professionals through Note PhotoTM which 
was a sub-module in the HOSxPTM program. Plan and result 
of each home visit was communicated and shared effectively. 
We also used Google MapTM to share the patient’s information 
on the internet which could be accessed by all kinds of 
electronic communication devices. This information included 
the patient’s name, HN, address, phone numbers, hospital 
appointment date, level of need for home visit, number visits 
made, and the last visit date. Google DriveTM was used to 
store information for later analysis.  
At least one day before the trip, family pharmacists 
reviewed the patient’s information from HOSxPTM, 
conventional medical records, Note PhotoTM and Google 
MapTM. Information from the last three to five visits was 
reviewed. Then plans for intervention and management, trip 
and sequence of home visits were made.  
During home visit, the family pharmacist observed and 
interviewed the patient according to the INHOMESSS 
concept.17 This concept helped assess the capacity and 
potential for self-care of the patient and their relatives, the 
patient’s disease status, the real illness, and risks toward 
family health. I-Immobility helped assess the patient’s 
capability in activities of daily living including getting up from 
bed, having meals, using restroom, doing household chores, 
and taking medications. N-Nutrition helped evaluate the 
patient’s nutritional status, favorite foods, food preparations, 
food storage, amount of food consumed, and dietary habits. 
H-Housing helped the pharmacist assess the patient’s housing 
whether it was comfortable, tidy, warm, private, and safe. It 
also assessed the space, surrounding, neighborhood, and 
relationship among family members. O-Other people helped 
assess role and responsibility of each family member toward 
the patient. It also helped identify the primary caregiver. M-
Medications helped the pharmacist evaluate medication use 
and the preparation of each dosing. It also assessed the use 
of medications, herbs and nutritional supplements other than 
those prescribed by the doctor. This could indicate the 
patient’s self-care behaviors. E-Examinations was employed 
for physical examination and daily living assessment. The 
evaluation could help reveal the real illness of the patient. S-
Safety helped assess the household safety so that home 
improvement could be made. For example, furniture re-
arrangement could help avoid accidents, especially falls, 
among the elderly. S-Spiritual health was used to assess 
beliefs and values of all family members. Finally, S-Services 
helped indicate the preference and access to healthcare 
facilities, communication methods with such facilities, when to 
contact such facilities, and other nearby healthcare facilities 
available. Family pharmacists considered all aspects of 
INHOMESSS to better understand the problems and offer the 
best solutions for the patient’s DRPs and DRSs.  
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All information observed and interviewed and the detail of 
all actions taken were recorded on the relevant forms as 
previously mentioned. All information was further electronically 
recorded and shared on Note PhotoTM for all professionals to 
prepare for the following visit. Comments and advices from 
relevant professionals could be added and shared. The latest 
information of the patient was updated in all databases 
including Google MapTM and Google CalendarTM.  In addition, 
case manager pharmacist contacted the patient’s primary 
physician, if needed, for advice and shared solutions. All 
information and summary was updated and readily available 
for planning the following visit.  
 
Data analysis  
Demographic and clinical data of each of individual 
patients were presented. These included gender, age, number 
and kind of diseases, marital status, occupation, payment 
scheme, caregiver, level of need for home visit at the start of 
the study, and the experience on home visit. Frequency and 
percentage of such characteristics were also presented. The 
need level at visit 3, or visit 2, if applicable, was presented for 
each of individual patients. Frequency and percentage of the 
need change were also presented.  
  
 
 
Results  
 
Of all 15 patients, the majority was referred from in-patient 
pharmacists (11 patients, or 73 . 3 3%) followed by the out-
patient pharmacist, nurse at CAPD unit, social worker, and 
nurse at a sub-district health promoting hospital (one patient 
each). All 15 patients were classified as a level A of need for 
home visit. There were more women (60.00%) than men 
(Table 1). Their age ranged from 39 to 80 years with an 
average of 61 years. Most of them were in the age of 61 – 70 
years old (53.33%), married (46.67%), not working (80.00%), 
under the universal coverage (UC) payment scheme 
(93 .33%) , having care givers to take care of medication use 
(60.00%). All patients had hypertension and more than one 
underlying disease. Thirteen patients had diabetes (86.67%) 
with an average HbA1C before the first visit of 10.26% (Table 
1).  
There were 47 home visits for 15 patients with an average 
of 3 visits per patient. The most and least numbers were 7 
and 1 visits respectively. Slightly more than half of the total 
visits were done by pharmacists only (53.33%) followed by 
pharmacists accompanied with a CAPD unit nurse (20.00%), 
and pharmacists accompanied with a nurse from sub-district 
health promoting hospital (13.33%). At the end of the study, 
almost two-thirds of the patients remained at level A of need 
(60.00%) while the rest (40.00%) changed to level B (Table 
2).  
 
 
 Table 1  Characteristics of the patients (N = 15). 
 
 
No. Gender Age  
(yrs.) 
No. of underlying 
diseases 
Underlying disease HbA1C 
(%) 
Marital status Occupation Payment 
scheme* 
Having  
care giver 
1 Male 42 3 HTN, DM, DLP 13.0 Single Small business UC Yes 
2 Female 60 3 HTN, DM, DLP 15.5 Widowed Labor  UC No 
3 Male 64 2 HTN, HIVs - Widowed None UC Yes 
4 Female 67 5 HTN, DM, DLP, IHD, CKD 8.5 Widowed None UC Yes 
5 Female 51 3 HTN, DM, HIVs 8.0 Widowed None UC No 
6 Female 46 3 HTN, DM, DLP 13.0 Married None UC No 
7 Male 64 3 HTN, DM, DLP 9.1 Single None UC Yes 
8 Female 61 2 HTN, DM 13.8 Married Small business UC No 
9 Male 39 3 HTN, Gout, CKD(CAPD) - Married None UC No 
10 Female 68 3 HTN, DM, DLP 10.8 Widowed None Civil servant Yes 
11 Female 69 3 HTN, DM, DLP 7.6 Married None UC Yes 
12 Female 67 3 HTN, DM, DLP 7.0 Married None UC Yes 
13 Male 78 4 HTN, DM, DLP, CVA 7.5 Widowed None UC No 
14 Male 80 4 HTN, DM, DLP, CKD 8.1 Married None UC Yes 
15 Female 63 4 HTN, DM, DLP, CKD (CAPD) 11.5 Married None UC Yes 
Note:  
HTN = hypertension   DM = diabetes mellitus  DLP = dyslipidemia    HIV = human immunodeficiency viral infection 
IHD = ischemic heart disease  CKD = chronic kidney disease CAPD = continuous ambulatory peritoneal dialysis   CVA = cardiovascular accidents  
UC = universal coverage   
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 Table 2  Home visits and level of need for home visit (N = 15).   
No.  Professional referring the patient for home visit Number of 
visits 
received 
No. of visits 
provided by family 
pharmacist 
Professionals accompanying 
the team 
Need level at the 
end of home 
visits 
1 Out-patient pharmacist  7 6 Social worker (1 visit) A 
2 In-patient pharmacist 3 2 IPD pharmacist (1 visit) B 
3 Social worker 1 1 None A 
4 In-patient pharmacist 3 3 None B 
5 In-patient pharmacist 4 4 None B 
6 In-patient pharmacist 3 3 None A 
7 Out-patient pharmacist 2 2 None B 
8 In-patient pharmacist 5 5 None A 
9 CAPD unit nurse 3 1 CAPD nurse (1 visit) and nurse from 
sub-district health promoting hospital (1 
visit)  
A 
10 Nurse from sub-district health promoting hospital 2 1 Nurse from sub-district health 
promoting hospital (1 visit)  
A 
11 In-patient pharmacist 1 1 None A 
12 In-patient pharmacist 2 2 None B 
13 In-patient pharmacist 5 4 OPD internal medicine nurse (1 visit)  A 
14 In-patient pharmacist 2 1 CAPD nurse (1 visit)  B 
15 In-patient pharmacist 4 2 CAPD nurse (2 visit) A 
 
Of 47 home visits, DRPs were found in 40 visits (85.11%) 
with a total of 7 8  DRPs. DRPs were found in all patients at 
their first visit. Of 78 DRPs, the most frequently found was 
medication non-adherence (93.59%). Regarding drug related 
sufferings or DRSs, seven patients (46.67%) who collectively 
experienced 29 DRPs were found that their medications 
caused DRSs to themselves and their family members. The 
most frequently found DRS was stress and anxiety related to 
the use of medications and their side effects which was found 
in 6 of 15 patients (40.00%). In addition, other health-related 
problems that could affect medication use were found in 10 
patients (66.67%). A total of 125 times of medication use were 
affected. The patient limited ability to use medications was the 
most frequently found cause (52.00%), followed by a lack of 
knowledge on diseases and medications, their belief and 
anxiety about diseases and medications, and financial 
problem.  
 
Two problem managements could be classified. The family 
pharmacists could manage the problems for the patient with 
or without the help from or co-operation with other 
professionals. Without help or co-operation, it was found that 
family pharmacists could provide knowledge or advice about 
diseases and relevant life-style managements (23 advices), 
and medication use (31 advices) to all patients at all 47 visits. 
Caregivers, if available, were also given such knowledge. In 
addition, the family pharmacists prepared 19 drug-use devices 
for 10 patients. For the management that needed co-operation 
with others, a total of 17 co-operations were found with 12 co-
operations with professionals in the hospital and 5 with those 
outside the hospital. All co-operations were successful.    
 
 
Discussions and Conclusion  
 
To test the benefit of the guideline for home visits for family 
pharmacists of Samutsakhon Hospital, we selected 15 
patients with drug-related problems and suspected drug-
related sufferings. All patients with chronic diseases had a  
level A of need for home visit. We found that all patients had 
more than two underlying diseases and an average of eight 
medications for chronic illnesses. Thirteen of them had 
diabetes with an average HbA1C of 10.26%. Our patient 
sample had more severe illnesses and more complicate 
problems than the study of Suradechawut and colleagues.13 
In Suradechawut’s work, HbA1C of 8.7%, four medications for 
chronic illnesses and only two underlying diseases by average 
were found. Patients in Suradechawut’s study experienced an 
overt improvement in the outcomes with the use of self-
efficacy driven strategy. In our present study, only 40% of the 
patients improved from level A to B of need for continuing 
home visit. In addition, patients in our study struggled with 
DRPs while those in Suradechawut’s study were more likely 
to face dietary challenges. The results of the two studies were 
therefore different.  
At the end of home visit, 6 patients (patient numbers 2, 4, 
5, 7, 12 and 14) improved from level A to B of need. The 
improvement could be due to the willingness of the patients 
and their caregivers to follow the pharmacist’s advice. As a 
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part of the success, family pharmacists could identify and finds 
ways to solve problems and sufferings related to drug use, 
and encourage the patients and caregivers for such 
improvement. In doing so, family pharmacists acting as the 
patient’s delegate sought helps from and co-operations with 
other involving parties.  
Our present study was a part of the development of the 
guideline for home visits for family pharmacists based on the 
concept of seamless care. With a drug use counseling 
provided before hospital discharge and a follow-up home visit, 
more appropriate drug use and adherence and better 
outcomes were found. These findings were consistent with the 
study of Polpoat15 which also reported that discharge 
counseling and home visit provided by pharmacists reduced 
DRPs and improved treatment outcomes among the elderly 
patients. Furthermore, Apisitsak’s study found that home visit 
accompanied with pharmaceutical care service at the hospital 
in patients using warfarin resulted in a decrease in adverse 
drug events and a larger number of patients with INR within 
therapeutic range.14 Like our study, both studies employed a 
seamless care, from hospital to home care, with pharmacists 
as the primary coordinator.  
Our study was somewhat disappointing with 60% of the 
patients remaining at the highest level of need for home visit. 
Their problems could be more severe and complicate that 
needed more time to solve. For example, patient number 1 
had diabetes with poor glycemic control. With a poor eyesight, 
he could not see clearly and could not self-inject his insulin. 
At all seven home visits, non-adherence to medication use 
was found. Other health-related problems that could worsen 
the medication use included his negligence on medication 
use, perceived severity of his illness, narcotic addiction, poor 
dietary habit, and his wound care problem. We also found that, 
based on the Transtheoretical Model Stage of Change, it took 
six visits for him to start to change his behavior from pre-
contemplation to contemplation stage (data not shown).  
Based on the INHOMESSS concept to assess the patient 
and caregiver’s capacity and potential in self-care, disease 
severity, real illness, and risk toward family health, we found 
that all patients could perform daily activities. At the end of the 
study, 20.00% of patients could take care of their own 
medication use. For those with diabetes, could not achieve an 
adequate glycemic control since they could not control their 
diet. Ten patients (66.67%) had their blood pressure at mild 
to severe level ( 141/100 mmHg). Among 13 patients with 
poor glycemic control, a better HbA1C was found in six of 
them at the end of the study (data not shown).   
As 33.33% of the patients were suspected of adverse drug 
reactions and another 3 3 . 3 3% with suspected causes other 
than drugs. Family pharmacists provided advice to solve the 
problems to most of them (93.33%) . All but one patient lived 
with their family members. Only two patients had an absolute 
positive belief toward self-care while 13 of them (86.67%) had 
mixed beliefs. These patients had a high trust on healthcare 
facilities. All of them preferred receiving continuous care at 
Samutsakorn Hospital while 46.67% preferred sub-district 
health promoting hospital for minor health problems and mild 
wound care (data not shown).  
Our preliminary study shows a promising result that the 
guideline for home visits for family pharmacists of 
Samutsakhon Hospital could be used in the actual practice. 
Other healthcare settings could try this guideline with some 
adaptations to suit their context. Co-operation of the 
multidisciplinary team is also a key factor for success.  
This study was not free from limitations. A small sample 
size of 15 patients made it difficult to summarize the results 
as the average measure. More subjects are needed in the 
future studies. With a relatively short period of study time, the 
long-term beneficial effect could not be reflected. Therefore, 
we recommend future studies with a longer study period. In 
addition, some patients were provided with a small number of 
home visits. A longer duration of study is again needed to 
allow for more visits.   
In conclusion, home visits following the guideline for home 
visits for family pharmacists of Samutsakhon Hospital could 
be conducted and could help reduce the need for home visit 
in 40% of 15 patients. Future studies should have more 
patients and a longer study period to allow for more visits.   
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